Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001903934-22-000001
Filing Date
2022-01-18
Accepted
2022-01-18 13:20:06
Documents
1
Effectiveness Date
2022-01-18
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8488
  Complete submission text file 0001903934-22-000001.txt   9574
Mailing Address 71 KINGSWAY LONDON X0 WC2B 6ST
Business Address 71 KINGSWAY LONDON X0 WC2B 6ST 44 20 7421 7081
SV Biotech Crossover Opportunities Fund LP (Filer) CIK: 0001903934 (see all company filings)

EIN.: 981618485 | State of Incorp.: X0
Type: D | Act: 33 | File No.: 021-429725 | Film No.: 22534586